Cite
Nickolls S, Mace H, Fish R, et al. A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. Adv Pharmacol Sci. 2011;2011:608912doi: 10.1155/2011/608912.
Nickolls, S., Mace, H., Fish, R., Edye, M., Gurrell, R., Ivarsson, M., Pitcher, T., Tanimoto-Mori, S., Richardson, D., Sweatman, C., Nicholson, J., Ward, C., Jinks, J., Bell, C., Young, K., Rees, H., Moss, A., Kinloch, R., & McMurray, G. (2011). A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. Advances in pharmacological sciences, 2011608912. https://doi.org/10.1155/2011/608912
Nickolls, Sarah, et al. "A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain." Advances in pharmacological sciences vol. 2011 (2011): 608912. doi: https://doi.org/10.1155/2011/608912
Nickolls S, Mace H, Fish R, Edye M, Gurrell R, Ivarsson M, Pitcher T, Tanimoto-Mori S, Richardson D, Sweatman C, Nicholson J, Ward C, Jinks J, Bell C, Young K, Rees H, Moss A, Kinloch R, McMurray G. A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. Adv Pharmacol Sci. 2011;2011:608912. doi: 10.1155/2011/608912. Epub 2011 Nov 28. PMID: 22162674; PMCID: PMC3226534.
Copy
Download .nbib